Biogen
Develops neurological medicines spanning MS, rare disease, Alzheimer’s, and complement-mediated conditions.
$218.19
After-hours close−0.30 (−0.14%)
At close$218.49(−1.36%)
| Date | Estimate | Reported | Surprise |
|---|---|---|---|
| Oct 2026 | $2.04 | — | — |
| Jul 2026 | $2.94 | $3.60 | +22.4% |
| Apr 2026 | $3.05 | $3.57 | +17.0% |
| Feb 2026 | $1.63 | $1.99 | +22.1% |
| Oct 2025 | $3.88 | $4.81 | +24.0% |
The latest year is open to everyone — the 41 quarters behind it read with an account. Sign in | |||
| Jul 2025 | |||
| May 2025 | |||
| Feb 2025 | |||
| Oct 2024 | |||
| Aug 2024 | |||
| Apr 2024 | |||
| Feb 2024 | |||
| Nov 2023 | |||
| Jul 2023 | |||
| Apr 2023 | |||
| Feb 2023 | |||
| Oct 2022 | |||
| Jul 2022 | |||
| May 2022 | |||
| Feb 2022 | |||
| Oct 2021 | |||
| Jul 2021 | |||
| Apr 2021 | |||
| Feb 2021 | |||
| Oct 2020 | |||
| Jul 2020 | |||
| Apr 2020 | |||
| Jan 2020 | |||
| Oct 2019 | |||
| Jul 2019 | |||
| Apr 2019 | |||
| Jan 2019 | |||
| Oct 2018 | |||
| Jul 2018 | |||
| Apr 2018 | |||
| Jan 2018 | |||
| Oct 2017 | |||
| Jul 2017 | |||
| Apr 2017 | |||
| Jan 2017 | |||
| Oct 2016 | |||
| Jul 2016 | |||
| Apr 2016 | |||
| Jan 2016 | |||
| Oct 2015 | |||
| Jul 2015 | |||
| Report date | EPS est | EPS | Surprise | Revenue est | Revenue | Surprise |
|---|---|---|---|---|---|---|
| Oct 29, 2026 | $2.04 | — | — | $2.64B | — | — |
| Jul 29, 2026 | $2.94 | $3.60 | +22.4% | $2.46B | $2.74B | +11.2% |
| Apr 29, 2026 | $3.05 | $3.57 | +17.0% | $2.29B | $2.48B | +8.4% |
| Feb 6, 2026 | $1.63 | $1.99 | +22.1% | $2.20B | $2.28B | +3.5% |
| Oct 30, 2025 | $3.88 | $4.81 | +24.0% | $2.34B | $2.45B | +4.9% |
The latest year is open to everyone — the 41 quarters behind it read with an account. Sign in | ||||||
| Jul 31, 2025 | ||||||
| May 1, 2025 | ||||||
| Feb 12, 2025 | ||||||
| Oct 30, 2024 | ||||||
| Aug 1, 2024 | ||||||
| Apr 24, 2024 | ||||||
| Feb 13, 2024 | ||||||
| Nov 8, 2023 | ||||||
| Jul 25, 2023 | ||||||
| Apr 25, 2023 | ||||||
| Feb 15, 2023 | ||||||
| Oct 25, 2022 | ||||||
| Jul 20, 2022 | ||||||
| May 3, 2022 | ||||||
| Feb 3, 2022 | ||||||
| Oct 20, 2021 | ||||||
| Jul 22, 2021 | ||||||
| Apr 22, 2021 | ||||||
| Feb 3, 2021 | ||||||
| Oct 21, 2020 | ||||||
| Jul 22, 2020 | ||||||
| Apr 22, 2020 | ||||||
| Jan 30, 2020 | ||||||
| Oct 22, 2019 | ||||||
| Jul 23, 2019 | ||||||
| Apr 24, 2019 | ||||||
| Jan 29, 2019 | ||||||
| Oct 23, 2018 | ||||||
| Jul 24, 2018 | ||||||
| Apr 24, 2018 | ||||||
| Jan 25, 2018 | ||||||
| Oct 24, 2017 | ||||||
| Jul 25, 2017 | ||||||
| Apr 25, 2017 | ||||||
| Jan 26, 2017 | ||||||
| Oct 26, 2016 | ||||||
| Jul 21, 2016 | ||||||
| Apr 21, 2016 | ||||||
| Jan 27, 2016 | ||||||
| Oct 21, 2015 | ||||||
| Jul 24, 2015 | ||||||